U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Forms & Submission Requirements
  5. Drug Master Files (DMFs)
  6. Drug Master File (DMF) Templates
  1. Drug Master Files (DMFs)

Drug Master File (DMF) Templates

The following templates recommend elements to include in certain DMF submissions:

In these letters, list the submission type and, if applicable, the amendment type as laid out below:

DMF Submission and Amendment Types

Submission Type

Amendment Type

Original (New)

 

Administrative Amendment

  • Change of Agent/Address/Contact Person
  • Change of Holder/Address/Contact Person
  • Change of DMF Subject (Title)
  • Change of DMF Type
  • Agent Appointment

Annual Report

 

Letter of Authorization

 

Withdrawal of Letter of Authorization

 

Meeting

  • Meeting Package
  • Meeting Request

Quality Amendment

  • Controls Information
  • Facility Information
  • Formulation Information
  • Manufacture Information
  • Microbiology Information
  • New Item*
  • Packaging Information
  • Stability Information

Response to Administrative Filing Issue

 

Response to Deficiency, Complete Response, Information Request or Additional Comments Letter

 

REMS—Risk Evaluation and Mitigation Strategy

  • REMS Final
  • REMS Assessment
  • REM Assessment Methodology
  • REMS Revision
  • REMS Modification—Due to Safety Labeling Changes
  • REMS Modification—Major
  • REMS Modification—Minor
  • REMS Proposal—Standard
  • REMS Correspondence

Other

Other

* For Type III and Type IV DMFs, new item represents a new item in the DMF, such as a rubber stopper, cap, and so forth.

Back to Top